Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Investor Overview

Investor Overview

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

News Releases

Date Title and Summary Additional Formats
Toggle Summary Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference Call
WILMINGTON, Mass. --(BUSINESS WIRE)--Jul. 16, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2019 financial results on Wednesday, July 31 st , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, July
View HTML
Toggle Summary Charles River Laboratories to Open Flexible Vivarium Space for Clients in South San Francisco
WILMINGTON, Mass. & SAN FRANCISCO --(BUSINESS WIRE)--Jul. 9, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the planned opening of the Charles River Accelerator and Development Lab (CRADL™) in South San Francisco in early 2020.
View HTML
Toggle Summary Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor Conferences
WILMINGTON, Mass. --(BUSINESS WIRE)--Jun. 3, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: Jefferies 2019 Global Healthcare Conference in New York on Wednesday, June 5 th , at 8:30 a.m.
View HTML
Toggle Summary Charles River Laboratories Invests in Resero Analytics™
Access to Resero’s TurboToxicology™ will provide faster delivery of high-quality toxicology reports WILMINGTON, Mass. --(BUSINESS WIRE)--May 16, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has invested in Resero Analytics™, a software company focused on
View HTML

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)